# MedShape, Inc.: Form D filings

MedShape, Inc., a biotechnology company in Atlanta, GA, filed 11 Form D notices with the SEC between 2009 and 2014. The latest, on August 22, 2014, reports $700,000 sold of a $4 million offering to 2 investors.

Find out what MedShape, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20MedShape%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=MedShape%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmedshape-inc-1463845)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20MedShape%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=MedShape%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmedshape-inc-1463845)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Georgia](https://specstream.ai/data/form-d/state/georgia): 1,337 rows, by operating companies, filed since November 1, 2024, $66.85, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/georgia
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1575 NORTHSIDE DRIVE, NW, SUITE 440, Atlanta, GA, 30318
- Phone: (404) 249-9155
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Georgia
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1463845

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 22, 2014 | Amendment | $4,000,000 | $700,000 | $3,300,000 | 2 | Jul 28, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384514000003/0001463845-14-000003-index.htm) |
| Aug 7, 2014 | New notice | $4,000,000 | $350,000 | $3,650,000 | 1 | Jul 28, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384514000002/0001463845-14-000002-index.htm) |
| Feb 27, 2013 | Amendment | $8,000,000 | $6,057,007 | $1,942,993 | 9 | Jun 18, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384513000001/0001463845-13-000001-index.htm) |
| Aug 15, 2012 | Amendment | $8,000,000 | $2,540,627 | $5,459,373 | 4 | Jun 18, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384512000003/0001463845-12-000003-index.htm) |
| Jun 29, 2012 | New notice | $8,000,000 | $2,500,019 | $5,499,981 | 3 | Jun 18, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384512000002/0001463845-12-000002-index.htm) |
| Jul 19, 2011 | Amendment | $7,000,000 | $5,687,751 | $1,312,249 | 18 | Mar 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384511000004/0001463845-11-000004-index.htm) |
| May 12, 2011 | Amendment | $7,000,000 | $190,978 | $6,809,022 | 4 | Mar 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384511000003/0001463845-11-000003-index.htm) |
| Mar 29, 2011 | New notice | $4,200,000 | $124,981 | $4,075,019 | 2 | Mar 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384511000002/0001463845-11-000002-index.htm) |
| Sep 15, 2009 | Amendment | $10,000,000 | $9,785,108 | $214,892 | 24 | May 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384509000003/0001463845-09-000003-index.htm) |
| Aug 7, 2009 | Amendment | $10,000,000 | $3,270,131 | $6,729,869 | 16 | May 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384509000002/0001463845-09-000002-index.htm) |
| Jun 4, 2009 | New notice | $10,000,000 | $150,000 | $9,850,000 | 1 | May 21, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463845/000146384509000001/0001463845-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Niles Noblitt | Director |  |
| Paul F. Hills | Director |  |

## Other biotechnology companies in Georgia that filed recently

- [Opus Medical Therapies, LLC](https://specstream.ai/data/form-d/company/opus-medical-therapies-llc-1785788) $485,089 · Sep 22, 2026
- [Airway Therapeutics, Inc.](https://specstream.ai/data/form-d/company/airway-therapeutics-inc-1733867) $43.5 million · Sep 9, 2026
- [FEMASYS INC](https://specstream.ai/data/form-d/company/femasys-inc-1339005) $30 million · Aug 20, 2026

[Every Form D from the week of Aug 18, 2014](https://specstream.ai/data/form-d/week/2014-08-18) · [All recent filings in Georgia](https://specstream.ai/data/form-d/state/georgia) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what MedShape, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).